Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich region will report the highest number of bird flu cases by the end of 2024?
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
WHO and CDC reports
U.S. Declares Bird Flu Emergency on July 25th, Moderna Secures $176 Million for Vaccine
Jul 29, 2024, 01:00 AM
The U.S. government has issued a Declaration of Emergency on July 25th due to the significant potential for a public health emergency from influenza A viruses with pandemic potential. Secretary Becerra has authorized the FDA Commissioner to issue Emergency Use Authorizations (EUA) for avian flu vaccines. In response, the Liverpool vaccine factory is preparing pre-pandemic H5N1 bird flu vaccines as a first line of defense, according to Nigel Hilton, head of the plant. Moderna has secured a $176 million contract from the HHS to develop a new mRNA vaccine for bird flu. Additionally, Sinergium Biotech will share its bird flu vaccine data with manufacturers in low- and middle-income countries to accelerate a fair rollout if a pandemic occurs, according to the World Health Organization (WHO). This initiative aims to enhance global pandemic preparedness and equitable access to vaccines.
View original story
Finland • 25%
United States • 25%
France • 25%
Germany • 25%
West • 25%
Midwest • 25%
South • 25%
Northeast • 25%
Limited to 1-5 countries • 25%
Spread to 6-10 countries • 25%
Spread to 11-20 countries • 25%
Spread to 21+ countries • 25%
Less than 50 • 25%
50-100 • 25%
101-200 • 25%
More than 200 • 25%
California • 25%
Texas • 25%
New York • 25%
Other • 25%
Poultry • 25%
Cattle • 25%
Swine • 25%
Other • 25%
United States • 25%
China • 25%
India • 25%
Other • 25%
Colorado • 25%
California • 25%
Texas • 25%
Other • 25%
California • 25%
Texas • 25%
Florida • 25%
Other • 25%
California • 25%
Texas • 25%
Florida • 25%
Other • 25%
California • 25%
Michigan • 25%
Colorado • 25%
Other • 25%
Only British Columbia • 25%
British Columbia and other provinces • 25%
Multiple provinces excluding British Columbia • 25%
No new cases reported • 25%
Moderna • 25%
Other • 25%
Pfizer • 25%
Sinergium Biotech • 25%